CEFEPIME HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Cefepime Hydrochloride, and what generic alternatives are available?
Cefepime Hydrochloride is a drug marketed by Acs Dobfar, Astral, Fosun Pharma, Hospira Inc, Qilu, Sagent Pharms Inc, and Samson Medcl. and is included in eight NDAs.
The generic ingredient in CEFEPIME HYDROCHLORIDE is cefepime hydrochloride. There are twenty drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the cefepime hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cefepime Hydrochloride
A generic version of CEFEPIME HYDROCHLORIDE was approved as cefepime hydrochloride by ACS DOBFAR on March 20th, 2008.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CEFEPIME HYDROCHLORIDE?
- What are the global sales for CEFEPIME HYDROCHLORIDE?
- What is Average Wholesale Price for CEFEPIME HYDROCHLORIDE?
Summary for CEFEPIME HYDROCHLORIDE
US Patents: | 0 |
Applicants: | 7 |
NDAs: | 8 |
Finished Product Suppliers / Packagers: | 7 |
Raw Ingredient (Bulk) Api Vendors: | 114 |
Clinical Trials: | 60 |
Patent Applications: | 379 |
Formulation / Manufacturing: | see details |
DailyMed Link: | CEFEPIME HYDROCHLORIDE at DailyMed |
![CEFEPIME HYDROCHLORIDE drug patent expirations Drug patent expirations by year for CEFEPIME HYDROCHLORIDE](/p/graph/s/t/CEFEPIME_HYDROCHLORIDE-patent-expirations.png)
Recent Clinical Trials for CEFEPIME HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Meiji Seika Pharma Co., Ltd. | Phase 3 |
Allecra | Phase 2 |
Linical Co., Ltd. | Phase 2 |
Pharmacology for CEFEPIME HYDROCHLORIDE
Drug Class | Cephalosporin Antibacterial |
Anatomical Therapeutic Chemical (ATC) Classes for CEFEPIME HYDROCHLORIDE
US Patents and Regulatory Information for CEFEPIME HYDROCHLORIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Acs Dobfar | CEFEPIME HYDROCHLORIDE | cefepime hydrochloride | INJECTABLE;INJECTION | 065441-001 | Mar 20, 2008 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Samson Medcl | CEFEPIME HYDROCHLORIDE IN PLASTIC CONTAINER | cefepime hydrochloride | POWDER;INTRAVENOUS | 209408-001 | Aug 21, 2018 | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Fosun Pharma | CEFEPIME HYDROCHLORIDE | cefepime hydrochloride | INJECTABLE;INJECTION | 090291-001 | Dec 21, 2010 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Astral | CEFEPIME HYDROCHLORIDE | cefepime hydrochloride | INJECTABLE;INJECTION | 212721-002 | Jul 21, 2020 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |